These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 19002462

  • 1. Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma.
    Kim KB, Hwu WJ, Papadopoulos NE, Bedikian AY, Camacho LH, Ng C, Hernandez IM, Frost AM, Jack MA, Hwu P.
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):161-7. PubMed ID: 19002462
    [Abstract] [Full Text] [Related]

  • 2. Temozolomide in combination with docetaxel in patients with advanced melanoma: a phase II study of the Hellenic Cooperative Oncology Group.
    Bafaloukos D, Gogas H, Georgoulias V, Briassoulis E, Fountzilas G, Samantas E, Kalofonos Ch, Skarlos D, Karabelis A, Kosmidis P.
    J Clin Oncol; 2002 Jan 15; 20(2):420-5. PubMed ID: 11786569
    [Abstract] [Full Text] [Related]

  • 3. The clinical efficacy of combination of docetaxel and temozolomide in previously treated patients with stage IV melanoma.
    Yoon C, Papadopoulos NE, Camacho LH, McIntyre S, Alvarado GC, Bedikian AY, Hwu P, Kim KB.
    Melanoma Res; 2010 Feb 15; 20(1):43-7. PubMed ID: 19952963
    [Abstract] [Full Text] [Related]

  • 4. Phase II multicentre study of temozolomide in combination with interferon alpha-2b in metastatic malignant melanoma.
    García M, del Muro XG, Tres A, Crespo C, Valladares M, López JJ, Rifà J, Pérez X, Filipovich E, Germà-Lluch JR.
    Melanoma Res; 2006 Aug 15; 16(4):365-70. PubMed ID: 16845333
    [Abstract] [Full Text] [Related]

  • 5. Temozolomide in combination with interferon alpha-2b in patients with metastatic melanoma: a phase I dose-escalation study.
    Agarwala SS, Kirkwood JM.
    Cancer; 2003 Jan 01; 97(1):121-7. PubMed ID: 12491513
    [Abstract] [Full Text] [Related]

  • 6. A phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma.
    Larkin JM, Hughes SA, Beirne DA, Patel PM, Gibbens IM, Bate SC, Thomas K, Eisen TG, Gore ME.
    Br J Cancer; 2007 Jan 15; 96(1):44-8. PubMed ID: 17146474
    [Abstract] [Full Text] [Related]

  • 7. Phase I/II study of a cisplatin-taxol-dacarbazine regimen in metastatic melanoma.
    Papadopoulos NE, Bedikian A, Ring S, Kim KB, Hwu WJ, Gerber DL, Homsi J, Hwu P.
    Am J Clin Oncol; 2009 Oct 15; 32(5):509-14. PubMed ID: 19506454
    [Abstract] [Full Text] [Related]

  • 8. Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic melanoma.
    Alrwas A, Papadopoulos NE, Cain S, Patel SP, Kim KB, Deburr TL, Bassett R, Hwu WJ, Bedikian AY, Davies MA, Woodman SE, Hwu P.
    Melanoma Res; 2014 Aug 15; 24(4):342-8. PubMed ID: 24743052
    [Abstract] [Full Text] [Related]

  • 9. Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma.
    Ott PA, Chang JL, Oratz R, Jones A, Farrell K, Muggia F, Pavlick AC.
    Chemotherapy; 2009 Aug 15; 55(4):221-7. PubMed ID: 19451711
    [Abstract] [Full Text] [Related]

  • 10. Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide).
    Xia C, Leon-Ferre R, Laux D, Deutsch J, Smith BJ, Frees M, Milhem M.
    Cancer Chemother Pharmacol; 2014 Oct 15; 74(4):691-7. PubMed ID: 25062770
    [Abstract] [Full Text] [Related]

  • 11. Biochemotherapy with temozolomide, cisplatin, vinblastine, subcutaneous interleukin-2 and interferon-alpha in patients with metastatic melanoma.
    González Cao M, Malvehy J, Martí R, Conill C, Sánchez M, Martín M, Carrera C, Herrero J, Gascón P, Mellado B, Castel T, Puig S.
    Melanoma Res; 2006 Feb 15; 16(1):59-64. PubMed ID: 16432457
    [Abstract] [Full Text] [Related]

  • 12. Temozolomide in combination with cisplatin in patients with metastatic melanoma: a phase II trial.
    Tas F, Argon A, Camlica H, Topuz E.
    Melanoma Res; 2005 Dec 15; 15(6):543-8. PubMed ID: 16314741
    [Abstract] [Full Text] [Related]

  • 13. Phase I dose finding study of carboplatin, paclitaxel, and temozolomide in advanced solid tumors.
    Movva S, Verschraegen CF, Rabinowitz I, Mangalik A, Parks V, Lee FC.
    Melanoma Res; 2011 Feb 15; 21(1):76-9. PubMed ID: 21169871
    [Abstract] [Full Text] [Related]

  • 14. A phase 2 trial of sequential temozolomide chemotherapy followed by high-dose interleukin 2 immunotherapy for metastatic melanoma.
    Tarhini AA, Kirkwood JM, Gooding WE, Moschos S, Agarwala SS.
    Cancer; 2008 Oct 01; 113(7):1632-40. PubMed ID: 18720480
    [Abstract] [Full Text] [Related]

  • 15. Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain: high rate of thromboembolic events (CALGB 500102).
    Krown SE, Niedzwiecki D, Hwu WJ, Hodgson L, Houghton AN, Haluska FG, Cancer and Leukemia Group B.
    Cancer; 2006 Oct 15; 107(8):1883-90. PubMed ID: 16986123
    [Abstract] [Full Text] [Related]

  • 16. Alternating chemo-immunotherapy with temozolomide and low-dose interleukin-2 in patients with metastatic melanoma.
    Masucci GV, Månsson-Brahme E, Ragnarsson-Olding B, Nilsson B, Wagenius G, Hansson J.
    Melanoma Res; 2006 Aug 15; 16(4):357-63. PubMed ID: 16845332
    [Abstract] [Full Text] [Related]

  • 17. A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, temozolomide, interleukin 2, and IFN-alpha 2B in patients with metastatic melanoma.
    Atkins MB, Gollob JA, Sosman JA, McDermott DF, Tutin L, Sorokin P, Parker RA, Mier JW.
    Clin Cancer Res; 2002 Oct 15; 8(10):3075-81. PubMed ID: 12374674
    [Abstract] [Full Text] [Related]

  • 18. Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma.
    Korones DN, Benita-Weiss M, Coyle TE, Mechtler L, Bushunow P, Evans B, Reardon DA, Quinn JA, Friedman H.
    Cancer; 2003 Apr 15; 97(8):1963-8. PubMed ID: 12673724
    [Abstract] [Full Text] [Related]

  • 19. Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study.
    Hwu WJ, Lis E, Menell JH, Panageas KS, Lamb LA, Merrell J, Williams LJ, Krown SE, Chapman PB, Livingston PO, Wolchok JD, Houghton AN.
    Cancer; 2005 Jun 15; 103(12):2590-7. PubMed ID: 15861414
    [Abstract] [Full Text] [Related]

  • 20. A biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, temozolomide (Temodal), interferon-alfa and interleukin-2 for metastatic melanoma: a phase II study.
    Ron IG, Sarid D, Ryvo L, Sapir EE, Schneebaum S, Metser U, Asna N, Inbar MJ, Safra T.
    Melanoma Res; 2006 Feb 15; 16(1):65-9. PubMed ID: 16432458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.